Irrespective of the precise taxonomy of oligosarcomas, it can be expected that the identification of oligosarcomas as a distinct group within the family of IDH-mutant gliomas will facilitate their diagnosis in the future and will help to further elucidate the clinical and molecular characteristics of these tumors. This evidence concerns the gene IDH1 and glioma.